Health Technology Assessment (HTA) & PRA Lead, KSA

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.Position PurposeThe Health Technology Assessment (HTA) & PRA Capabilities Lead is a strategic role within Lilly Saudi Arabia's Pricing, Reimbursement & Access function. The position holds a dual mandate: providing the economic and HTA technical foundation that enables the PRA function to deliver on its access agenda and building enduring capability across the PRA and Key Account Management (KAM) functions.On the HTA side, the role works in close partnership with the PRA Leads and Market Access — who own access strategy, reimbursement strategy, and the affiliate value narrative — by developing the economic models, evidence packages, and HTA content that underpin payer submissions and conversations across SFDA and public sector and reimbursement institutions, and key institutions. On the capabilities side, the role designs and delivers structured learning programs that elevate PRA and KAM team performance, support world-class payer engagement, and develop individual talent.This role is critical to accelerating early access for Lilly innovations, sustaining access for in-line products, and equipping Lilly's PRA and KAM teams with the economic fluency required to engage Saudi health system decision-makers as the Kingdom's HTA and value-based reimbursement environment continues to mature in line with Vision 2030.Key ResponsibilitiesA. Health Technology Assessment & Economic Evidence•    Partner closely with the PRA Leads and Market Access to provide the economic tools, models, and HTA evidence required to execute the affiliate's payer and access strategy across Lilly's KSA portfolio.•    Develop, adapt, and validate health economic models — cost-effectiveness, budget impact, and cost-consequence analyses — tailored to the Saudi healthcare context, with robust local epidemiological, cost, and clinical assumptions.•    Produce the economic content and HTA components of payer submissions to SFDA, and public sector and reimbursement institutions, and other relevant payers — under the strategic direction of the PRA Leads, who own access and reimbursement outcomes.•    Support the PRA-led affiliate value narrative by supplying the underlying economic evidence, total cost of care arguments, and quantitative substantiation that translate clinical outcomes into payer-relevant language.•    Work side-by-side with the PRA Leads and cross-functional teams (Medical, Market Access, Brand, Regulatory, Finance, Supply) to embed HTA thinking early in launch planning and lifecycle management, ensuring the economic foundation is in place when access conversations happen.•    Maintain a forward-looking view of the Saudi HTA environment — monitoring SFDA economic submission requirements, CHI guidance, and emerging value-based frameworks — and translate this intelligence into recommendations for the PRA Director, PRA Leads, and affiliate leadership.•    Provide the economic modeling and evidence to support PRA-led early access initiatives, innovative pricing constructs (e.g., managed entry agreements, outcomes-based and risk-share arrangements), and access maintenance for in-line brands facing competitive entry or policy change.•    Engage with payer health economists, scientific committees, and HTA reviewers on technical and methodological matters, supporting the PRA Leads in defending submissions and shaping standards over time.•    Champion the integration of real-world evidence (RWE) and locally generated data into the affiliate's economic evidence base.B. PRA & KAM Capability Building•    Design and deliver a comprehensive capability-building program for the Saudi PRA function and the KAM team, covering HTA fundamentals, health economics, payer archetypes, value communication, account planning, and negotiation.•    Establish a structured curriculum spanning onboarding, intermediate, and advanced tracks — aligned to Lilly's global PRA competency framework and adapted to the KSA market context.•    Lead the rollout of payer engagement excellence programs — coaching teams on stakeholder mapping, evidence-led conversations, and account planning for tier-one Saudi institutions.•    Identify capability gaps through structured assessments and partner with Learning & Development, Global PRA, and the Hub to source, customize, or build training content.•    Mentor PRA colleagues and KAMs in HTA-relevant skills, including economic model interpretation, value story articulation, objection handling, and scientific committee engagement.•    Define and track capability KPIs (submission quality, payer engagement quality, individual development progression) and report progress to PRA and affiliate leadership.•    Foster a culture of continuous learning, peer development, and knowledge sharing within the PRA and KAM communities.C. Cross-Functional Leadership & Stakeholder Engagement•    Serve as the affiliate's subject-matter expert on HTA and health economics, providing the technical economic insight that informs the PRA Director's, PRA Leads', and brand teams' access strategy and value evidence decisions.•    Represent Lilly in external HTA forums, payer working groups, scientific societies (e.g., ISPOR), and policy roundtables relevant to the Saudi access environment.•    Partner with Global and International HEOR & RWE teams and Hub teams to ensure two-way flow of evidence, methods, and market insights.•    Contribute to the affiliate's environmental shaping and policy influence agend